Skip to content
Centauri Therapeutics selects first clinical candidate for immunotherapy against Gram-negative infections
We use cookies to ensure that we give you the best experience on our website. Please visit carb-x.org/legal/ for more information. By clicking “Ok”, you consent to the use of all cookies.OkI do not consent
Toggle navigation